Panacea Biotec Limited (NSE:PANACEABIO)
436.35
-7.45 (-1.68%)
Apr 9, 2025, 3:30 PM IST
Panacea Biotec Employees
Panacea Biotec had 1,936 employees as of March 31, 2024. The number of employees increased by 142 or 7.92% compared to the previous year.
Employees
1,936
Change (1Y)
142
Growth (1Y)
7.92%
Revenue / Employee
2.91M INR
Profits / Employee
-40.87K INR
Market Cap
26.73B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Apollo Hospitals Enterprise | 83,147 |
Zydus Lifesciences | 26,921 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Panacea Biotec News
- 3 months ago - Panacea Biotec subsidiary launches baby care products under “NikoMom” brand - Business Upturn
- 3 months ago - Panacea Biotec shares hit 5% upper circuit after securing Rs 127 crore vaccine supply contract from UNICEF - Business Upturn
- 3 months ago - Panacea Biotec secures Rs 127 crore UNICEF order for bivalent oral polio vaccine - Business Upturn
- 6 months ago - Panacea Biotec aims to launch dengue vaccine in next 2-3 years - Business Upturn
- 7 months ago - Panacea Biotec secures $20 million loan from DFC for vaccine capacity expansion - Business Upturn
- 7 months ago - Panacea Biotec shares surge over 3% in intraday trading - Business Upturn
- 8 months ago - Phase-3 clinical trial of dengue vaccine starts - The Times of India
- 8 months ago - Phase three clinical trial of India's own dengue vaccine, DengiAll, initiated - The Times of India